U.S. and New Zealand are the only countries that allow direct-to-consumer drug advertising, with companies spending over $1 billion monthly. FDA's attempts to regulate drug ads have been thwarted by ...

Pfizer and Valneva may have about two more years to wait before they make the first approval filing to the FDA for a Lyme disease vaccine, but that hasn’t stopped the companies collecting more ...

An update to the last time we visited the Theranos saga.ColdFusion Discord: <a href="https://discord.gg/coldfusionPrevious">https://discord.gg/coldfusionPrevious</a ...

Paxlovid, the most commonly used oral antiviral, is free through the end of 2024 for people with Medicare or Medicaid through a U.S. government patient assistance program operated by the drug’s maker, ...

But the Australian missionary, who has become a naturalised PNG citizen because of the decades he spent doing missionary work in PNG, would not back down. At a meeting for the church clergy in East ...

It is going to look a little bizarre, but there is a great reason behind the change… Nike have changed their logo on third kits to celebrate women's football. They explained their switch for ...

The Food and Drug Administration approved Novavax’s new COVID-19 vaccine Friday, a week after giving Pfizer and Moderna ... and syringes with the ... [+] logo of US biotech company Novavax.

A Reddit thread started Thursday titled, "What's wrong with the Facebook logo?" shows a blue lowercase "f" on a black background instead of a blue background with a white "f." Some users who have ...

A month has gone by since the last earnings report for Pfizer (PFE). Shares have lost about 5.9% in that time frame, underperforming the S&P 500. Will the recent negative trend continue leading up ...

To counter new forms of the virus, FDA approved updated vaccines from both Pfizer and Moderna last week. These new vaccines specifically target the KP.2 strain, a descendant of the Omicron variant.

Flagship Pioneering and Pfizer have added Quotient into their 10-program partnership, inking a deal to discover new targets for two programs in cardiovascular and renal diseases. The deal fits ...